comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 01:49:59 - browse：2689

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： ACA's risk program benefits Blue Cross Blue Shield insurers

Wikipedia

WSS

Hospitals are piloting generative AI tools as regulators play catch

New study raises questions about niacin and heart health

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Home health providers sue Medicare over payment cuts

A new drug could help frostbite victims avoid its ravages

Pandemic and All Hazards Preparedness Act needs lean update

knowledge

comprehensive

focus

After affirmative action ruling, medical educators look to 'holistic review'

Home health providers sue Medicare over payment cuts

United colonoscopy coverage change 'may cost lives,' doctors say

Opioid cravings were reduced by anti

Trump demands the U.S. pay no more for drugs than other countries … again

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Medicare proposal to cover medical devices draws a mixed reaction

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Psychedelics group wrestles with new pharma identity

Ukraine seeks to reclaim its role as a hub for clinical trials

entertainment

Wisconsin governor employs partial veto to fund schools for 4 centuries

Measles policy set amid Florida outbreak alarms vaccine proponents

White House announces new plan to address the growing threat of xylazine in overdose crisis

The U.S. needs a new definition of substance use “recovery”

Medicare Advantage enrollment hits roughly 33.4 million

WATCH: Why do our ears pop?

entertainment

Wikipedia

hotspot

explore